Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.

3R/4R-tau species are found in Alzheimer disease (AD) and ∼50% of Lewy body dementias at autopsy (LBD+tau); 4R-tau accumulations are found in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Digital image analysis techniques can elucidate patterns of tau pathology more precisely than traditional methods but repeatability across centers is unclear. We calculated regional percentage areas occupied by tau pathological inclusions from the middle frontal cortex (MFC), superior temporal cortex (STC), and angular gyrus (ANG) from cases from the University of Pennsylvania and the University of California San Diego with AD, LBD+tau, PSP, or CBD (n = 150) using QuPath. In both cohorts, AD and LBD+tau had the highest grey and white matter tau burden in the STC (p ≤ 0.04). White matter tau burden was relatively higher in 4R-tauopathies than 3R/4R-tauopathies (p < 0.003). Grey and white matter tau were correlated in all diseases (R2=0.43-0.79, p < 0.04) with the greatest increase of white matter per unit grey matter tau observed in PSP (p < 0.02 both cohorts). Grey matter tau negatively correlated with MMSE in AD and LBD+tau (r = -4.4 to -5.4, p ≤ 0.02). These data demonstrate the feasibility of cross-institutional digital histology studies that generate finely grained measurements of pathology which can be used to support biomarker development and models of disease progression.

[1]  M. Jinzaki,et al.  Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies , 2021, Brain communications.

[2]  D. Dickson,et al.  Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies , 2021, Neuropathology and applied neurobiology.

[3]  T. Montine,et al.  Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson’s disease , 2021, Journal of clinical and experimental neuropsychology.

[4]  A. Murzin,et al.  Structure-based classification of tauopathies , 2021, Nature.

[5]  L. Tian,et al.  Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology , 2021, Journal of Alzheimer's disease : JAD.

[6]  J. Trojanowski,et al.  Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology , 2021, Acta neuropathologica communications.

[7]  J. Trojanowski,et al.  Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body Dementias , 2021, Neurology.

[8]  D. Dickson,et al.  Deep Learning-Based Image Classification in Differentiating Tufted Astrocytes, Astrocytic Plaques, and Neuritic Plaques. , 2021, Journal of neuropathology and experimental neurology.

[9]  T. Yen,et al.  18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty , 2020, Scientific Reports.

[10]  J. Trojanowski,et al.  Tau pathology associates with in vivo cortical thinning in Lewy body disorders , 2020, Annals of clinical and translational neurology.

[11]  J. Trojanowski,et al.  Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer’s disease , 2020, Neuropathology and applied neurobiology.

[12]  Alzheimer's Disease Neuroimaging Initiative,et al.  Multimodal in vivo and postmortem assessments of tau in Lewy body disorders , 2020, Neurobiology of Aging.

[13]  John L. Robinson,et al.  Distribution patterns of tau pathology in progressive supranuclear palsy , 2020, Acta Neuropathologica.

[14]  Val J Lowe,et al.  Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. , 2020, JAMA neurology.

[15]  A. Murzin,et al.  Novel tau filament fold in corticobasal degeneration , 2020, Nature.

[16]  Mari Yoshida,et al.  Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration , 2020, Neuropathology : official journal of the Japanese Society of Neuropathology.

[17]  D. Irwin,et al.  Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases , 2020, Movement disorders : official journal of the Movement Disorder Society.

[18]  Rene L. Utianski,et al.  Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants , 2019, NeuroImage: Clinical.

[19]  L. Walker Glial tauopathy: Neurons optional? , 2019, The Journal of experimental medicine.

[20]  J. Trojanowski,et al.  Human tau pathology transmits glial tau aggregates in the absence of neuronal tau , 2019, The Journal of experimental medicine.

[21]  David T. Jones,et al.  Tau-positron emission tomography correlates with neuropathology findings , 2019, Alzheimer's & Dementia.

[22]  J. Trojanowski,et al.  Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies. , 2019, Radiology.

[23]  Jesse A. Brown,et al.  Evidence of corticofugal tau spreading in patients with frontotemporal dementia , 2019, Acta Neuropathologica.

[24]  B. Cullen,et al.  Neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[25]  Clifford R. Jack,et al.  Multimodal neuroimaging relationships in progressive supranuclear palsy. , 2019, Parkinsonism & related disorders.

[26]  G. Schellenberg,et al.  TRANSMISSION OF TAUOPATHY STRAINS IS INDEPENDENT OF THEIR ISOFORM COMPOSITION , 2019, Alzheimer's & Dementia.

[27]  I. Ferrer,et al.  Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies , 2019, Front. Aging Neurosci..

[28]  J. Trojanowski,et al.  Divergent patterns of TDP‐43 and tau pathologies in primary progressive aphasia , 2019, Annals of neurology.

[29]  C. Jack,et al.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.

[30]  J. Trojanowski,et al.  Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders , 2018, Annals of neurology.

[31]  Fabio Sambataro,et al.  Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data , 2018, Front. Aging Neurosci..

[32]  B. Miller,et al.  Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders , 2018, JAMA.

[33]  Janna H. Neltner,et al.  Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques. , 2018, Journal of Alzheimer's disease : JAD.

[34]  John L. Robinson,et al.  Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain , 2018, Acta Neuropathologica Communications.

[35]  J. Trojanowski,et al.  CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders , 2018, Neurology.

[36]  E. Londos,et al.  18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies , 2018, Scientific Reports.

[37]  Hanna Cho,et al.  Distinct patterns of amyloid‐dependent tau accumulation in Lewy body diseases , 2018, Movement disorders : official journal of the Movement Disorder Society.

[38]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[39]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[40]  F. Gage,et al.  Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology , 2017, The Journal of Neuroscience.

[41]  T. Montine,et al.  Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis , 2017, The Lancet Neurology.

[42]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[43]  C. Rowe,et al.  Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy , 2017, European journal of neurology.

[44]  David T. Jones,et al.  AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies , 2016, Annals of neurology.

[45]  Keith A. Johnson,et al.  Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. , 2016, JAMA neurology.

[46]  C. Adler,et al.  Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects. , 2016, Journal of Parkinson's disease.

[47]  M. Schain,et al.  Increased basal ganglia binding of 18 F‐AV‐1451 in patients with progressive supranuclear palsy , 2016, Movement disorders : official journal of the Movement Disorder Society.

[48]  D. Galasko,et al.  Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies. , 2016, Parkinsonism & related disorders.

[49]  N. Schuff,et al.  Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study , 2016, PloS one.

[50]  David Neil Manners,et al.  Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease , 2016, NeuroImage: Clinical.

[51]  John Q. Trojanowski,et al.  Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease , 2016, Alzheimer's & Dementia.

[52]  J. Trojanowski,et al.  Deep clinical and neuropathological phenotyping of Pick disease , 2016, Annals of neurology.

[53]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[54]  Alan J. Thomas,et al.  Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes , 2015, Acta Neuropathologica.

[55]  E. Tolosa,et al.  The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases , 2014, Movement disorders : official journal of the Movement Disorder Society.

[56]  T. Hortobágyi,et al.  Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias , 2014, Brain pathology.

[57]  Murray Grossman,et al.  A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank , 2014, Alzheimer's & Dementia.

[58]  H. Shill,et al.  Concomitant pathologies among a spectrum of parkinsonian disorders. , 2014, Parkinsonism & related disorders.

[59]  Mark Hallett,et al.  Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.

[60]  Ela Patel,et al.  Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. , 2012, Journal of neuropathology and experimental neurology.

[61]  John L. Robinson,et al.  Neuropathologic substrates of Parkinson disease dementia , 2012, Annals of neurology.

[62]  P. Pal,et al.  In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS , 2012, Neuroradiology.

[63]  B. Boeve,et al.  Rapid eye movement sleep behavior disorder and subtypes in autopsy‐confirmed dementia with Lewy bodies , 2012, Movement disorders : official journal of the Movement Disorder Society.

[64]  Clifford R. Jack,et al.  Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. , 2011, Parkinsonism & related disorders.

[65]  J. Trojanowski,et al.  Clinicopathological correlations in corticobasal degeneration , 2011, Annals of neurology.

[66]  Murray Grossman,et al.  Building an integrated neurodegenerative disease database at an academic health center , 2011, Alzheimer's & Dementia.

[67]  Dennis W. Dickson,et al.  Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.

[68]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[69]  Constantinos Kallis,et al.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? , 2011, Brain : a journal of neurology.

[70]  D. Dickson,et al.  Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.

[71]  C. Jack,et al.  Dementia with Lewy bodies and Alzheimer disease , 2010, Neurology.

[72]  Dag Aarsland,et al.  Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology , 2009, Alzheimer disease and associated disorders.

[73]  K. Jellinger,et al.  Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease , 2008, Acta Neuropathologica.

[74]  G. Halliday,et al.  The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.

[75]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[76]  A. Lees,et al.  Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.

[77]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[78]  Joseph James Duffy,et al.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.

[79]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[80]  H. Braak,et al.  Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability , 2005, Journal of neuropathology and experimental neurology.

[81]  E B Larson,et al.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both , 2005, Neurology.

[82]  P. Lantos,et al.  Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[83]  Masanori Kato,et al.  Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease , 2004, Acta Neuropathologica.

[84]  R. Armstrong,et al.  Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis , 2003, Histopathology.

[85]  D. Jeste,et al.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2003, Neurology.

[86]  A. Lees,et al.  Dementia with Lewy bodies from the perspective of tauopathy , 2003, Acta Neuropathologica.

[87]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[88]  Toshiki Nakai,et al.  Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies , 2002, Journal of the Neurological Sciences.

[89]  K. Jellinger,et al.  Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease , 2002, Journal of Neural Transmission.

[90]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[91]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[92]  J. Trojanowski,et al.  Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia. , 2018, Brain : a journal of neurology.

[93]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[94]  James T Becker,et al.  Research evaluation and prospective diagnosis of dementia with Lewy bodies. , 2002, Archives of neurology.

[95]  H. Chui,et al.  Neuropathologic Diagnosis of Alzheimer Disease: Interrater Reliability in the Assessment of Senile Plaques and Neurofibrillary Tangles , 1993, Alzheimer disease and associated disorders.